Tung Roger D
Insider CIK 1594857 · CNCE Chief Executive Officer, Director, 10% owner · FLKS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 203,300 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 156,675 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 170,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 200,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 200,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 200,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 151,600 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 205,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | U Tender | 2023-03-06 | 2023-03-06 | 12,389 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | U Tender | 2023-03-06 | 2023-03-06 | 13,274 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | U Tender | 2023-03-06 | 2023-03-06 | 121,873 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer | 2023-03-06 | 2023-03-06 | 57,916 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | U Tender | 2023-03-06 | 2023-03-06 | 756,427 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2023-01-06 | 2023-01-09 | 9,240 | $7.24 | $66.9K | 971,018 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2022-02-15 | 2022-02-16 | 13,480 | $3.09 | $41.7K | 980,258 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2022-01-28 | 2022-02-01 | 156,675 | — | $0 | 993,738 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2022-01-28 | 2022-02-01 | 52,225 | — | $0 | 837,063 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2022-01-06 | 2022-01-07 | 9,240 | $3.09 | $28.6K | 784,838 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2021-12-15 | 2022-01-07 | 7,500 | — | $0 | 794,078 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2021-12-14 | 2022-01-07 | 7,000 | — | $0 | 801,578 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2021-12-13 | 2021-12-15 | 6,700 | — | $0 | 4,522 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2021-12-13 | 2021-12-15 | 6,700 | $3.50 | $23.4K | 815,278 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2021-12-13 | 2021-12-15 | 6,700 | $3.62 | $24.3K | 808,578 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2021-02-17 | 2021-02-17 | 13,480 | $7.20 | $97.1K | 808,578 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2021-01-05 | 2021-01-07 | 205,000 | — | $0 | 205,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2021-01-05 | 2021-01-07 | 69,300 | — | $0 | 822,058 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2020-03-13 | 2020-03-16 | 14,601 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2020-03-13 | 2020-03-16 | 14,601 | $3.79 | $55.3K | 752,758 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2020-02-14 | 2020-02-19 | 151,600 | — | $0 | 151,600 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2020-02-14 | 2020-02-19 | 101,100 | — | $0 | 738,157 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2019-12-04 | 2019-12-06 | 13,166 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2019-12-04 | 2019-12-06 | 7,629 | $7.61 | $58.1K | 637,057 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2019-12-04 | 2019-12-06 | 13,166 | $4.41 | $58.1K | 644,686 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2019-04-23 | 2019-04-24 | 14,601 | — | $0 | 14,601 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2019-04-23 | 2019-04-24 | 14,601 | $3.79 | $55.3K | 631,520 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2019-04-10 | 2019-04-10 | 24,886 | — | $0 | 13,166 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2019-04-10 | 2019-04-10 | 24,886 | $4.41 | $109.7K | 616,919 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2019-03-31 | 2019-04-02 | 5,890 | $12.07 | $71.1K | 592,033 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2019-01-04 | 2019-01-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| FLKS Flex Pharma, Inc. | A Award deriv | 2018-07-25 | 2018-07-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2018-06-11 | 2018-06-12 | 1,000 | — | $0 | 597,923 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2018-03-31 | 2018-04-03 | 5,890 | $22.90 | $134.9K | 638,923 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2018-03-31 | 2018-04-13 | 5,890 | $22.90 | $134.9K | 598,923 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2018-03-02 | 2018-03-05 | 27,757 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2018-03-02 | 2018-03-05 | 27,757 | $4.58 | $127.1K | 650,855 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2018-03-02 | 2018-03-05 | 6,042 | $21.04 | $127.1K | 644,813 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2018-01-04 | 2018-01-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2017-11-22 | 2018-01-08 | 1,600 | — | $0 | 623,098 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2017-11-17 | 2017-11-20 | 7,340 | — | $0 | 27,757 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2017-11-17 | 2017-11-20 | 7,340 | $4.58 | $33.6K | 626,305 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2017-11-17 | 2017-11-20 | 1,607 | $20.91 | $33.6K | 624,698 | SEC↗ |
| FLKS Flex Pharma, Inc. | A Award deriv | 2017-11-08 | 2017-11-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2017-07-06 | 2017-07-10 | 80,000 | — | $0 | 618,965 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2017-01-04 | 2017-01-06 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2016-05-11 | 2016-05-12 | 19,610 | $10.55 | $206.9K | 538,965 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2016-01-11 | 2016-01-13 | 18,000 | — | $0 | 35,097 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2016-01-11 | 2016-01-13 | 18,000 | $4.58 | $82.4K | 519,355 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2016-01-07 | 2016-01-08 | 170,000 | — | $0 | 170,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2015-11-17 | 2015-11-23 | 350 | — | $0 | 488,467 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2015-11-17 | 2015-11-23 | 1,000 | — | $0 | 488,817 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2015-07-07 | 2016-01-13 | 12,888 | — | $0 | 501,355 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2015-07-07 | 2016-01-13 | 12,888 | — | $0 | 121,873 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2015-02-17 | 2015-02-19 | 28,495 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2015-02-17 | 2015-02-19 | 28,495 | $1.13 | $32.2K | 490,017 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | G Gift | 2014-12-12 | 2015-11-23 | 200 | — | $0 | 489,817 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2014-06-10 | 2014-06-12 | 203,300 | — | $0 | 203,300 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise deriv | 2014-05-22 | 2014-05-23 | 60,000 | — | $0 | 28,495 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | M Exercise | 2014-05-22 | 2014-05-23 | 60,000 | $1.13 | $67.8K | 461,522 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-19 | 25,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-19 | 50,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-19 | 100,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-19 | 4,424 | — | $0 | 13,274 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-19 | 8,850 | — | $0 | 8,850 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-19 | 17,699 | — | $0 | 401,522 | SEC↗ |